Alex M. Sykes

Alex M. Sykes

Auto-generated profile, based on publicly available information

Alex M. Sykes

Institute for Biomedicine and Glycomics Griffith University Nathan Queensland Australia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2023 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
JSJessica K. Smith
Jessica K. Smith
GMGeorge D. Mellick
George D. Mellick
ASAlex M. Sykes
Alex M. Sykes
Parkinson’s disease (PD) is a chronic neurodegenerative disease that is characterized by a loss of dopaminergic neurons in the substantia nigra pars compacta of the midbrain (SNpc). Extensive studies into genetic and cellular models of PD implicate protein trafficking as a prominent contributor to the death of these dopaminergic neurons. Considerable evidence also suggests the involvement of α-synuclein as a central component of the characteristic cell death in PD and it is a major structural constituent of proteinaceous inclusion bodies (Lewy bodies; LB). α-synuclein research has been a vital part of PD research in recent years, with newly discovered evidence suggesting that α-synuclein can propagate through the brain via prion-like mechanisms. Healthy cells can internalize toxic α-synuclein species and seed endogenous α-synuclein to form large, pathogenic aggregates and form LBs. A better understanding of how α-synuclein can propagate, enter and be cleared from the cell is vital for therapeutic strategies.

17 March 2021 in Genes
Verified
Journal Article
Open access
PDF file
SBSteven R. Bentley
Steven R. Bentley
IGIlaria Guella
Ilaria Guella
HSHolly E. Sherman
Holly E. Sherman
HNHannah Neuendorf
Hannah Neuendorf
ASAlex M. Sykes
Alex M. Sykes
GMGeorge D. Mellick
George D. Mellick
Parkinson’s disease (PD) is typically sporadic; however, multi-incident families provide a powerful platform to discover novel genetic forms of disease. Their identification supports deciphering molecular processes leading to disease and may inform of new therapeutic targets. The LRRK2 p.G2019S mutation causes PD in 42.5–68% of carriers by the age of 80 years. We hypothesise similarly intermediately penetrant mutations may present in multi-incident families with a generally strong family history of disease. We have analysed six multiplex families for missense variants using whole exome sequencing to find 32 rare heterozygous mutations shared amongst affected members. Included in these mutations was the KCNJ15 p.R28C variant, identified in five affected members of the same family, two elderly unaffected members of the same family, and two unrelated PD cases. Additionally, the SIPA1L1 p.R236Q variant was identified in three related affected members and an unrelated familial case. While the evidence presented here is not sufficient to assign causality to these rare variants, it does provide novel candidates for hypothesis testing in other modestly sized families with a strong family history. Future analysis will include characterisation of functional consequences and assessment of carriers in other familial cases.

25 June 2025 in The Journal of Physiology
Verified
Journal Article
Open access
XCXiaoyi Chen
Xiaoyi Chen
RFRocio Finol-Urdaneta
Rocio Finol-Urdaneta
MCMo Chen
Mo Chen
ASAlex M. Sykes
Alex M. Sykes
BGBingmiao Gao
Bingmiao Gao
LMLinlin Ma
Linlin Ma
Parkinson's disease (PD) is a complex, progressive neurodegenerative disorder driven by multiple pathogenetic factors, including oxidative stress, mitochondria dysfunction, neuroinflammation and ion imbalance. Recent evidence highlights the significant role of potassium channels in the pathophysiology of PD. We recently identified a PD‐linked genetic mutation in the KCNJ15 gene ( KCNJ15 p.R28C ), encoding the inwardly rectifying potassium channel Kir4.2, within a four‐generation family with familial PD. However, the role of the Kir4.2 channel in neurodegenerative diseases remains largely unexplored. This study aimed to elucidate the impact of the KCNJ15 p.R28C (Kir4.2 R28C ) mutation on the biophysical and biochemical properties of Kir4.2. Employing Kir4.2‐overexpressing HEK293T cells as a model, we investigated how the mutation affects the channel's functional properties, total protein expression, intracellular processing in the endoplasmic reticulum and lysosomes and plasma membrane trafficking. Patch clamp studies revealed that the Kir4.2 R28C mutation results in loss of channel function with significant dominant‐negative effects. This dysfunction is partially attributed to the substantial reduction in overall mutant channel protein expression compared to the wild‐type (Kir4.2 WT ). We observed that both Kir4.2 WT and Kir4.2 R28C proteins undergo glycosylation during the post‐translational modification process, albeit with differing protein turnover efficiencies. Furthermore, the Kir4.2 R28C mutant exhibits reduced stability and compromised plasma membrane trafficking capacity compared to Kir4.2 WT . These findings suggest that the Kir4.2 R28C mutant has unique biomolecular and biophysical characteristics distinct from the Kir4.2 WT channel, which potentially elucidates its role in the pathogenesis of PD. image Key points: Inwardly rectifying potassium channels are increasingly recognized for their critical role in the complex pathogenesis of Parkinson's disease (PD). We previously identified a genetic mutation, Kir4.2 R28C , in the inwardly rectifying potassium channel Kir4.2, which strongly segregates with familial PD in a multi‐generational pedigree. This study confirms Kir4.2 R28C as a loss‐of‐function mutation with significant dominant‐negative effects, impairing channel activity even in heterozygous conditions. The Kir4.2 R28C mutation significantly reduces overall protein levels, impairs protein stability and disrupts plasma membrane trafficking in in vitro cell models.

7 June 2022 in Proteomics – Clinical Applications
Verified
Journal Article
Open access
SWStephen A. Wood
Stephen A. Wood
PHPeter Hains
Peter Hains
AMArnaud Muller
Arnaud Muller
MHMelissa Hill
Melissa Hill
SPSusitha Premarathne
Susitha Premarathne
ASAlex M. Sykes
Alex M. Sykes
Purpose: Parkinson's disease (PD) is the second most prevalent neurodegenerative disease. It is generally diagnosed clinically after the irreversible loss of dopaminergic neurons and no general biomarkers currently exist. To gain insight into the underlying cellular causes of PD we aimed to quantify the proteomic differences between healthy control and PD patient cells.Experimental Design: Sequential Window Acquisition of all THeoretical Mass Spectra was performed on primary cells from healthy controls and PD patients.Results: In total, 1948 proteins were quantified and 228 proteins were significantly differentially expressed in PD patient cells. In PD patient cells, we identified seven significantly increased proteins involved in the unfolded protein response (UPR) and focused on cells with high and low amounts of PDIA6 and HYOU1. We discovered that PD patients with high amounts of PDIA6 and HYOU1 proteins were more sensitive to endoplasmic reticulum stress, in particular to tunicamycin. Data is available via ProteomeXchange with identifier PXD030723.Conclusions and Clinical Relevance: This data from primary patient cells has uncovered a critical role of the UPR in patients with PD and may provide insight to the underlying cellular dysfunctions in these patients.

25 October 2023 in Exploration of Medicine
Verified
Journal Article
Open access
PDF file
JSJessica K. Smith
Jessica K. Smith
GMGeorge D. Mellick
George D. Mellick
ASAlex M. Sykes
Alex M. Sykes
Aim: Parkinson’s disease (PD) is a complex, chronic neurodegenerative disorder with predominately sporadic etiology. Intricate genetic-environmental interactions lead to the hallmarks of the di

7 May 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
XCXiaoyi Chen
Xiaoyi Chen
RFRocio Finol-Urdaneta
Rocio Finol-Urdaneta
MCMo Chen
Mo Chen
ASAlex Sykes
Alex Sykes
BGBingmiao Gao
Bingmiao Gao
ASAlex Skye
Alex Skye
Parkinson’s disease (PD) is a complex, progressive neurodegenerative disorder driven by multiple pathogenetic factors, including oxidative stress, mitochondria dysfunction, neuroinflammation, and ion imbalance. Recent evidence highlights the significant role of potassium channels in the pathophysiology of PD. We recently identified a PD-linked genetic mutation in the KCNJ15 gene ( KCNJ15 p.R28C ), encoding the inwardly rectifying potassium channel Kir4.2, within a four-generation family with familial PD. However, the role of the Kir4.2 channel in neurodegenerative diseases remains largely unexplored. This study aimed to elucidate the impact of the KCNJ15 p.R28C (Kir4.2 R28C ) mutation on the biophysical and biochemical properties of Kir4.2. Employing Kir4.2-overexpressing HEK293T cells as a model, we investigated how the mutation affects the channel’s functional properties, total protein expression, intracellular processing in the endoplasmic reticulum and lysosomes, and plasma membrane trafficking. Patch clamp studies revealed that the Kir4.2 R28C mutation results in loss of channel function with significant dominant-negative effects. This dysfunction is partially attributed to the substantial reduction in overall mutant channel protein expression compared to the wild-type (Kir4.2 WT ). We observed that both Kir4.2 WT and Kir4.2 R28C proteins undergo glycosylation during the post-translational modification process, albeit with differing protein turnover efficiencies. Furthermore, the Kir4.2 R28C mutant exhibits reduced stability and compromised plasma membrane trafficking capacity compared to Kir4.2 WT . These findings suggest that the Kir4.2 R28C mutant has unique biomolecular and biophysical characteristics distinct from the Kir4.2 WT channel, which potentially elucidates its role in the pathogenesis of PD. Key Points: ➢ Inwardly rectifying potassium channels are increasingly recognized for their critical role in the complex pathogenesis of Parkinson’s disease (PD) ➢ We previously identified a genetic mutation, Kir4.2 R28C , in the inwardly rectifying potassium channel Kir4.2, which strongly segregates with familial PD in a multi- generational pedigree. ➢ This study confirms Kir4.2 R28C as a loss-of-function mutation with significant dominant- negative effects, impairing channel activity even in heterozygous conditions. ➢ The Kir4.2 R28C mutation significantly reduces overall protein levels, impairs protein stability and disrupts plasma membrane trafficking in in vitro cell models.
1